Axsome Therapeutics, Inc., a biopharmaceutical company dedicated to developing therapies for the treatment of pain and other central nervous system disorders, announced last month that the first patient has been enrolled in the CREATE-1 (CRPS Treatment Evaluation 1) study, a Phase 3 trial evaluating the…
Complex Regional Pain Syndrome, also known as Reflex Sympathetic Dystrophy, is a rare, incurable disorder that causes the brain to send pain signals to the body, even when there is no detectable reason for the pain. This condition causes many sufferers to have ongoing, bone-crushing…
Although Jim Broatch, executive vice president of the Reflex Sympathetic Dystrophy Syndrome Association, describes the pain associated with Complex Regional Pain Syndrome (CRPS) as greater than that of giving birth or having a digit amputated, there is widespread misunderstanding about the pain and limitations that…